Phase II trial with CLT-28643 as an adjuvant to surgery in patients requiring trabeculectomy
Latest Information Update: 20 Aug 2019
At a glance
- Drugs CLT 28643 (Primary)
- Indications Eye disorders
- Focus Therapeutic Use
- Sponsors Clanotech
Most Recent Events
- 20 Aug 2019 New trial record